B

Bruker

Manufactures analytical instruments for NMR diagnostics

Paralegal

Full-TimeDeadline 10/8/27
No salary listed
Mid
Beijing, China
In Person
LegalLegal Counsel & Legal Support

About the job

Requirements
  • Ability to work effectively in a global, cross-cultural environment.
  • Strong written and verbal communication skills.
  • Highly adaptable and resilient in the face of challenges and change.
  • Proactive, resourceful, and solutions-oriented mindset.
  • Strong organizational skills with attention to detail and ability to manage multiple priorities.
  • Commitment to the highest professional and ethical standards.
  • Ability to handle sensitive and confidential information with discretion.
Responsibilities
  • Conduct detailed legal research and analysis on PRC laws, regulations, and legal developments relevant to the company’s operations.
  • Monitor and assess regulatory changes and provide concise summaries with practical implications for internal stakeholders.
  • Monitor and track regulatory filings and corporate governance compliance requirements for PRC subsidiaries and representative offices.
  • Prepare legal memoranda, reports, and briefing materials to support senior legal counsel and business decision-making.
  • Coordinate legal input for internal teams and ensure timely, structured responses to business queries.
  • Draft, review, and revise commercial agreements, including customer, supplier, distribution, and service agreements, NDAs, and other standard documents.
  • Ensure contracts are consistent with approved templates, internal policies, and applicable legal requirements.
  • Maintain and enhance contract templates in collaboration with regional legal stakeholders.
  • Manage the contract lifecycle, including tracking execution, amendments, renewals, and terminations.
  • Maintain structured contract repositories and ensure proper documentation, version control, and audit readiness.
  • Support litigation, arbitration, and dispute matters in China in coordination with internal legal counsel and external advisors.
  • Organize and manage case files, including documentation, evidence, and correspondence.
  • Coordinate between internal stakeholders and external counsel to ensure alignment and timely task execution.
  • Monitor case progress, deadlines, and deliverables, and support preparation of internal reporting materials.
  • Support engagement and management of external legal counsel and service providers, including coordination of engagement terms and renewals.
  • Monitor legal spend, assist with budgeting, and review invoices for alignment with agreed scope and cost expectations.
  • Maintain external vendor records and ensure adherence to internal procurement and governance processes.
  • Provide operational support to the China legal team and coordinate workflows across stakeholders.
  • Assist with governance matters, including board and shareholder resolutions for PRC entities.
  • Facilitate document legalization, notarization, and translation as needed.
  • Maintain and improve legal documentation systems, databases, and knowledge-management processes.
  • Support preparation of presentations, reports, and materials for China and global management.
  • Contribute to legal process-improvement initiatives that enhance the efficiency, consistency, and scalability of legal support.

About the company

Bruker makes analytical and diagnostic instruments used by researchers and industries. Its products help analyze materials and biological samples to reveal chemical structure, composition, and properties, with notable roots in nuclear magnetic resonance (NMR) technology and a broad portfolio beyond that field. The company works by designing and selling instruments such as analytical tools that collect data from samples (for example, signals from nuclei in NMR or other spectroscopic methods) and provide insights to researchers. Bruker differentiates itself through a long history of developing advanced technologies, a focus on innovation in scientific instrumentation, and a global product range serving life sciences, materials science, and environmental analysis, supported by steady investment in research and development. Its goal is to equip researchers and industries with reliable tools to push the boundaries of what is possible in science and discovery.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Billerica, Massachusetts

Founded

1960

Get referred to Bruker

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 28, 2026 timsUltra AIP and timsOmni launches deepen proteomics and oligonucleotide workflows.
  • August 10, 2026 MIMETAS deal expands Bruker into human-relevant drug discovery models.
  • UC Berkeley ordered over $6 million of Bruker NMR systems, delivering 2027 revenue.

What critics are saying

  • Bruker’s first-half 2026 organic revenue declined 0.8%, exposing fragile demand recovery.
  • Academic spending stayed soft in 2026, while tariffs and currency pressured results.
  • If MIMETAS and fusion remain niche, Bruker’s acquisition-heavy strategy destroys capital returns.

What makes Bruker unique

  • Bruker owns timsTOF proteomics, NMR, microscopy, and microphysiological systems under one platform.
  • Bruker’s August 31 XFlash 7200 FIRE raises SEM-EDS throughput beyond conventional detector designs.
  • Bruker’s BEST superconductors supply ITER, Wendelstein 7-X, CERN, and fusion demonstrators.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Employee Stock Purchase Plan
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Disability Insurance
  • Life Insurance
  • Dental Insurance
  • Flexible Work Hours
  • Employee Discounts

Growth & Insights and Company News

6 month growth

10%

1 year growth

13%

2 year growth

13%
Business Wire
Oct 14th, 2026
Bruker Completes Acquisition of PhenomeX

Bruker Corporation (Nasdaq: BRKR) today announced that it has completed the acquisition of PhenomeX, a leading provider of single-cell biology research tools...

Financial Times
Sep 28th, 2026
Bruker advances functional proteomics with novel timsUltra AIP and timsOmni workflows for drug discovery & development and disease biology research.

Bruker advances functional proteomics with novel timsUltra AIP and timsOmni workflows for drug discovery & development and disease biology research. Sep 28 2026 12:00 BST * MultiDIA-PASEF significantly increases protein sequence coverage on timsUltra AIP * ProteoScape connects PASEF discovery with rapid prm-PASEF target validation * Spectronaut(R) AI transfer learning accelerates adaptation to new MS capabilities * Guided PASEF EXciD enables high-throughput glycopeptide characterization * Integrated HDX-MS workflows advance protein conformation and interaction studies * timsOmni(TM) enables RNA and DNA top-down structural and native RNA analysis SINGAPORE-(BUSINESS WIRE)-Sep. 28, 2026- At the Human Proteome Organization World Congress 2026, Bruker Corporation (Nasdaq: BRKR) today announced unique new timsUltra AIP and timsOmni workflows for deeper protein-sequence coverage, targeted validation, mobility-resolved glycopeptide characterization, structural proteomics, and oligonucleotide analysis. Multi-enzyme dia-PASEF provides additional peptide information for investigations of isoforms and proteoforms, while ProteoScape workflows connect PASEF discovery with prm-PASEF target validation on the same timsTOF platform. Novel timsOmni and integrated HDX-MS workflows extend structural analysis to glycopeptides, proteins, and nucleic acids.

MarketScreener
Sep 21st, 2026
Bruker Corporation receives order from University of California, Berkeley for high-field nmr systems for major upgrade of Magnetic Resonance research infrastructure.

Bruker Corporation receives order from University of California, Berkeley for high-field nmr systems for major upgrade of Magnetic Resonance research infrastructure. Published on 09/21/2026 at 09:36 am EDT S&P Capital IQ Bruker Corporation announced a multi-system order from University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instrumentation at the Pines Magnetic Resonance Center. The investment will enhance access to next-generation NMR technologies, including 800 MHz?class instrumentation. The investment is centered on a Bruker AV NEO-X 800 MHz spectrometer equipped with a cryogenically cooled MAS CryoProbe, complemented by several additional NMR systems and upgrades supporting solid-state, solution-state and Dynamic Nuclear Polarization (DNP) research. The UC Berkeley NMR order exceeds USD 6 million and is expected to be delivered in 2027. (C) S&P Capital IQ - 2026

U.S. Securities and Exchange Commission
Sep 19th, 2026
10-K

Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities

U.S. Securities and Exchange Commission
Sep 18th, 2026
10-Q

Unaudited Condensed Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023